Kevin represents a wide range of health care providers and related organizations across the U.S., including physicians and nonphysician practitioners, group practices, hospitals and health systems, clinical laboratories, behavioral therapy providers, pharmacies, ambulatory surgery centers, skilled nursing facilities, hospices, home health agencies, medical equipment suppliers, ambulance suppliers, independent diagnostic testing facilities, pharmaceutical and medical device manufacturers, management service organizations, group purchasing organizations, and private equity and other strategic investors.
Kevin practices in all areas of health care law, and has significant experience advising clients on a variety of complex regulatory and transactional matters involving federal and state fraud and abuse laws (including the federal Anti-Kickback Statute, federal Stark Law, False Claims Act liability, and state kickback/fee-splitting and self-referral laws), corporate practice of medicine, HIPAA and state privacy laws, physician/hospital arrangements, telemedicine, marketing relationships and practices, concierge and private pay medicine, and scope of practice issues. He advises health care providers, suppliers and private equity investors on both the buy and sell sides on regulatory and compliance issues impacting health care mergers, acquisitions, joint ventures, and other strategic transactions.
Kevin also has unique experience in representing providers in connection with their third-party payor relationships. He counsels and represents clients in all aspects of provider enrollment and credentialing, including initial enrollment filings, revalidations, physician opt-outs, changes in ownership and other mandatory disclosures, and appealing adverse enrollment determinations (e.g., revocations, denials, and effective date determinations). He also advises health care providers on a variety of compliance issues concerning Medicare, Medicaid, and other third-party payor billing and reimbursement requirements.
Health Care Transactions
Health Care Compliance
Representative matters may include engagements before joining Troutman Pepper.
Articles + Publications
04.16.24
California's AB 3129: Implications for Private Equity Investments in Physician Practices
Firm News
04.10.24
Troutman Pepper Advises Leading Global Clinical Trial Supply Company Myonex in Back-to-Back Acquisitions
Firm Events
03.19.24
Troutman Pepper Webinar Series: Multistate Pharmacy Compliance 101 - Legal Landmines for Multistate Pharmacies
Firm News
11.01.23
Troutman Pepper Advises AMETEK on $1.9B Acquisition of Paragon Medical
Articles + Publications
09.13.23
Multistate Pharmacies: A Prescription for Navigating the Regulatory Maze
Firm News
04.17.23
Troutman Pepper Advises Guardian Capital Partners in Sale of Tactical Medical Solutions